Private equity continues to reshape healthcare delivery. From physician practice management to health IT and post-acute care, PE capital is driving consolidation across every subsector. This page tracks the major trends, deal announcements, and market dynamics that matter for healthcare entrepreneurs and physician practice owners.
2024-2026 Market Overview
Despite higher interest rates cooling some activity, healthcare PE deal volume remains robust. Physician practice management (PPM) continues to attract premium multiples, with dermatology, GI, and ophthalmology leading consolidation activity.
Major 2024-2026 Trends
1. Gastroenterology Emerges as Hot Specialty
GI has become one of the most active consolidation sectors. ASC-based colonoscopy volumes, aging demographics, and fragmented ownership make it attractive for roll-up strategies.
- Gastro Health continues aggressive expansion under Leonard Green
- GI Alliance (Waud Capital) building national footprint
- US Digestive Health (Audax) active in mid-Atlantic
- Multiples: 6-9x EBITDA for quality practices
2. Dermatology Premium Persists
Despite market maturity, dermatology continues commanding premium valuations:
- 8-12x EBITDA for quality platforms
- Consolidation pace slowing as market matures
- Focus shifting to operational improvement vs. pure add-on growth
- Second and third PE transactions occurring for mature platforms
3. MSO Model Under Regulatory Scrutiny
FTC and state regulators increasing focus on healthcare PE:
- Corporate practice of medicine concerns growing
- Transparency requirements expanding
- Quality metrics and outcomes under review
- Antitrust scrutiny for large platform combinations
4. Value-Based Care Integration
PE platforms increasingly pursuing value-based arrangements:
- Medicare Advantage capitation opportunities
- ACO participation and shared savings
- Quality bonuses and care management fees
- Payer partnerships driving strategic value
5. Healthcare IT M&A Acceleration
Technology investments supporting practice consolidation:
- Revenue cycle management platforms
- Patient engagement solutions
- Analytics and population health tools
- AI-enabled documentation and coding
Notable Recent Deals
| Deal | Sector | Buyer/PE Firm | Significance |
|---|---|---|---|
| Large GI platform recapitalization | Gastroenterology | Top-tier PE | Set new GI valuation benchmarks |
| National derm platform secondary sale | Dermatology | Strategic | Third PE transaction; premium exit |
| Multi-state ophthalmology merger | Ophthalmology | Leading PPM PE | Regional consolidation continues |
| RCM technology acquisition | Health IT | Growth equity | Tech-enabled services demand |
Note: Specific deal details often remain confidential. Check sources like PE Hub, Becker's Hospital Review, and Healthcare Dive for verified announcements.
What This Means for Practice Owners
If You're Considering Selling
- Valuations remain strong for quality practices in target specialties
- Competition for deals means leverage for sellers with multiple providers
- Preparation matters clean financials and reduced owner dependency drive premium pricing
- Run a process multiple bidders create competitive tension
If You're Staying Independent
- Market consolidation is changing competitive dynamics
- Payer negotiations increasingly favor scale
- Recruitment PE platforms aggressively recruiting physicians
- Strategic positioning consider partnerships, MSOs, or joint ventures
Know Your Practice Value
Curious what your practice might be worth in this market? Request a confidential valuation estimate.
Request Confidential ValuationKey Industry News Sources
Stay informed on healthcare PE activity:
- PE Hub Deal announcements and fund news
- Becker's Hospital Review Healthcare M&A coverage
- Healthcare Dive Industry trends and analysis
- Modern Healthcare Comprehensive industry news
- Fierce Healthcare Digital health and payer news
- Medical Group Management Association (MGMA) Practice management insights
Understanding the Market Cycle
Healthcare PE typically operates on 4-6 year investment cycles:
- Platform acquisition Initial investment at moderate multiple
- Add-on consolidation 2-3 years of aggressive acquisition
- Operational improvement Margin enhancement, system integration
- Exit preparation Position for sale to larger PE or strategic
- Recapitalization Sale to next buyer; cycle repeats
Market Timing
While timing the market is difficult, current conditions favor sellers in target specialties. Interest rates have stabilized, PE firms have significant dry powder to deploy, and the demographic wave of retiring physicians is accelerating.
Related Resources
- Healthcare PE Firms: Directory of major investors
- Selling to PE: How transactions work
- Practice Valuation: How values are determined
- M&A News: Deal announcements and trends